Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com

Posted by on Jan 4th, 2025

Equities research analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report issued on Thursday. The brokerage set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Trading Up 4.4 %

Arcadia Biosciences stock opened at $6.36 on Thursday. The stock has a 50 day moving average of $4.61 and a two-hundred day moving average of $3.53. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $10.31. The stock has a market capitalization of $8.68 million, a price-to-earnings ratio of -1.49 and a beta of 1.19.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Read More

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.